Finally, available options for the treatment of therapeutically challenging solid tumors by targeting DOT1L are discussed. Recently, the DOT1L gene has been found overexpressed and/or amplified in ...

Dr. Alan Tan spoke with CURE® about what patients with kidney cancer and providers who treat it may be able to learn from ...

Solid tumors that originate in the deep internal organs, such as the pancreas, liver, and ovary, have poor prognoses due to the difficulties of diagnosing ...

A survey of the nation's oncologists showed that professional burnout has reached a new high (59% vs 45% in 2013), and fewer ...

Cancer Check Labs is live in 44 states and has the ability to test for any solid tumor with a 40 ml blood draw.

In a retrospective study of 265 patients with drug-resistant solid organ cancers, ‘Exacta AI’ provided at least seven therapy ...

Nuvectis is also advancing NXP900 for YES1/SRC-expressing solid tumors, with promising early data showing no dose-limiting ...

Alphamab Oncology (Stock Code: 9966.HK) and CSPC Pharmaceutical Group Co., Ltd. ('CSPC') (Stock Code: 1093.HK) jointly announced that anti-HER2 biparatopic antibody-drug conjugate (ADC) JSKN003 has ...

A person’s lifetime risk of cancer might be partly established before they are even born, a new mouse study says.Resear ...

Day One Biopharma's OJEMDA FDA approval for pediatric glioma, but market concerns remain. Check out why I rate DAWN stock as ...

A research team from Nagoya University Graduate School of Medicine has made a major discovery on how the CUL5 gene affects ...